Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Wolfe

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Molecular Pharmacology|November 1, 1989
Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administrationW Lee, B B Wolfe
Biotechniques|October 1, 1995
Use of insoluble fusion proteins to purify antibodiesJ Luo, B B Wolfe
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1986
Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvertD W Gil, B B Wolfe
Annals of the New York Academy of Sciences|May 10, 1995
Development of selective antisera for muscarinic cholinergic receptor subtypesB B Wolfe, R P Yasuda
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995
3-Isobutyl-1-methylxanthine increases alpha-1-adrenergic receptor sensitivity and density in DDT1-MF2 smooth muscle cellsJ B Schachter, B B Wolfe
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1985
Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclaseD W Gil, B B Wolfe
Molecular Pharmacology|September 1, 1984
[3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerizationG R Luthin, B B Wolfe
Molecular Pharmacology|March 1, 1992
Cyclic AMP differentiates two separate but interacting pathways of phosphoinositide hydrolysis in the DDT1-MF2 smooth muscle cell lineJ B Schachter, B B Wolfe
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1985
Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brainG R Luthin, B B Wolfe
Brain Research. Developmental Brain Research|October 24, 2000
Developmental differences in alternative splicing of the NR1 protein in rat cortex and cerebellumK L Prybylowski, B B Wolfe
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Molecular Pharmacology|November 1, 1989
Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administrationW Lee, B B Wolfe
Biotechniques|October 1, 1995
Use of insoluble fusion proteins to purify antibodiesJ Luo, B B Wolfe
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1986
Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvertD W Gil, B B Wolfe
Annals of the New York Academy of Sciences|May 10, 1995
Development of selective antisera for muscarinic cholinergic receptor subtypesB B Wolfe, R P Yasuda
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995
3-Isobutyl-1-methylxanthine increases alpha-1-adrenergic receptor sensitivity and density in DDT1-MF2 smooth muscle cellsJ B Schachter, B B Wolfe
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1985
Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclaseD W Gil, B B Wolfe
Molecular Pharmacology|September 1, 1984
[3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerizationG R Luthin, B B Wolfe
Molecular Pharmacology|March 1, 1992
Cyclic AMP differentiates two separate but interacting pathways of phosphoinositide hydrolysis in the DDT1-MF2 smooth muscle cell lineJ B Schachter, B B Wolfe
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1985
Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brainG R Luthin, B B Wolfe
Brain Research. Developmental Brain Research|October 24, 2000
Developmental differences in alternative splicing of the NR1 protein in rat cortex and cerebellumK L Prybylowski, B B Wolfe
Pageof 10